In its latest quarterly report, Cisco’s security segment posted a 2% year-over-year revenue decline, driven by customer migration from on-premise appliances to native cloud offerings and lower demand for legacy firewall products. Total security revenues reached approximately $2.1 billion for the quarter, compared with $2.15 billion a year earlier. Despite the downturn, Cisco highlighted that its next-generation XDR and SASE platforms saw combined bookings growth of 15%, suggesting early traction among enterprise clients seeking unified threat detection and secure access solutions.

Braun Stacey Associates increased its holdings in Cisco by 7.5% during the third quarter, adding 23,800 shares to reach a total position valued at $23.35 million as of the latest 13F filing. Other notable shifts include Postrock Partners raising its stake by 4.5% to 3,480 shares and Mount Vernon Associates adding 150 shares to hold 41,379 shares. Collectively, institutional and hedge fund ownership accounts for over 73% of outstanding shares, underscoring continued confidence among professional investors despite mixed segment performance.

Following the earnings release, multiple Wall Street firms revised their outlook on Cisco’s stock. Bank of America upgraded to a buy rating and lifted its 12-month target by 11.8%, while Morgan Stanley increased its target by 10.9% and maintained an overweight stance. Piper Sandler and Barclays also raised targets by 22.9% and 7.0% respectively, citing strong free cash flow and accelerating software subscription renewals. The consensus view among 26 analysts now reflects a moderate buy consensus, emphasizing the company’s expanding software margin and potential cross-sell opportunities within its installed base.

During the past quarter, Director Kristina M. Johnson sold 13,481 shares and CEO Charles Robbins sold 116,734 shares, representing 17.9% and 14.2% reductions in their respective holdings. These transactions generated proceeds of roughly $1.04 million and $9.02 million. Insiders have collectively sold over one million shares valued at approximately $81.4 million in the last 90 days. While such sales often reflect routine diversification, they coincide with management’s reaffirmation of full-year guidance calling for earnings per share between 4.08 and 4.14 and continued investment in R&D to drive next-gen product development.